Companies Our Team Has Worked With
Selected experience across pharma, biotech, and healthcare
Curated, compliant engagements that turn KOL conversations into actionable Medical Affairs, Commercial, and Market Access strategy. Paired with modern KOL mapping and AI search visibility.
Selected experience across pharma, biotech, and healthcare
Athera pairs traditional advisory board expertise with modern KOL intelligence and AI search visibility, so the strategic voices around your brand are also the voices shaping how payers, prescribers, and patients find information online.
Curated, compliant engagements across Medical Affairs, Commercial, and Market Access. Pre-meeting planning, expert recruitment, facilitation, and reporting.
Identify, profile, and prioritize key opinion leaders across therapeutic areas by clinical authority, payer reach, and digital influence.
Generative Engine Optimization for life sciences. Help your brand surface responsibly inside AI answers from ChatGPT, Perplexity, and Google AI.
We work with your team to articulate meeting objectives and identify the right forum, whether national or regional, in-person, virtual, or hybrid.
Start a project →Hand-picked clinicians, payers, and key opinion leaders matched to your scientific and commercial questions. We handle contracting and compliance.
See our KOL approach →Discussion guides, scientific workshops, and moderation techniques that encourage balanced participation and generate actionable recommendations.
Advisory capability →Venue and technology coordination, on-site moderation, honoraria management, and reporting aligned to Sunshine Act, EFPIA, and transparency requirements.
Talk to our team →Topline summaries and detailed consensus papers capturing key findings, recommendations, and next steps to inform development and market access strategies.
Request consultation →Structured medical content, schema, and citation strategy to help your brand appear responsibly within AI-generated answers and traditional search.
Talk to our team →Pharmaceutical and biotech companies face complex regulatory environments, rapid scientific progress, and high-stakes market decisions. A well-run advisory board distills expert input into strategies that move clinical, regulatory, and commercial outcomes.
Every panel is composed around a strategic question, not filled from a database. We optimize for diversity of expertise and balance of perspective.
Fair-market-value honoraria, transparency reporting, conflict-of-interest workflows, and documentation handled end-to-end.
Topline summaries, detailed consensus papers, and executive briefs, formatted so the output lands in your launch plan, not the archive.
Designed around the strategic decision at hand, with the right experts in the room.
Inform pricing, reimbursement, and value propositions. We manage payer recruitment, compliance, logistics, and moderation.
Engage clinicians and researchers to refine trial design, assess endpoints, and align programs with regulatory expectations.
Explore emerging technologies, novel therapeutic areas, and translational research opportunities that guide long-term strategy.
Traditional KOL lists are static and citation-heavy. We build a clearer picture, weighting clinical authority, payer relationships, society leadership, conference presence, and digital footprint alongside publications.
Publications, society roles, payer ties, speaking history, and digital presence.
See how KOLs connect through co-authorship, society leadership, and advisory history.
Mapping tuned to the specific clinical and commercial questions in front of your team.
FMV-priced engagement workflows from scoping through contracting and honoraria.
Define objectives, recruit advisors, craft the agenda, and develop pre-reads and pre-meeting surveys to gather baseline insight.
Moderate the discussion, encourage contribution from every expert, and manage logistics and compliance throughout the meeting.
Immediate topline summaries, comprehensive reports, executive briefs, evaluations, and final regulatory reporting.
Project-based support sized to your objectives. A single meeting, a multi-phase series, or ongoing KOL and visibility work across a launch cycle.
One advisory board, end-to-end, from objective setting through consensus paper.
A connected series of boards and workshops aligned to development, launch, or access milestones.
Continuous KOL mapping, advisory support, and AI search positioning across a launch cycle.
Fill out the form below and our team will be in touch to discuss your needs.
Share a few details and our team will follow up to scope the right engagement.